Clinical Trials Logo

Recurrent or Metastatic Gastric Cancer clinical trials

View clinical trials related to Recurrent or Metastatic Gastric Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT01283204 Active, not recruiting - Clinical trials for Recurrent or Metastatic Gastric Cancer

Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer

Start date: February 2010
Phase: Phase 2
Study type: Interventional

This study is to evaluate the antitumor activity (i.e. progression free survival, overall survival, response rate, etc), safety and quality of life in patient with recurrent or metastatic gastric cancer during 4-regimen (i.e. SP, FL/Tax, FL/Doc, FOLFOX) based chemotherapy. In addition, it is to evaluate efficacy and adverse events of anticancer agents according to the results of pharmacogenetic study.